The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Various types of inhalers, including short- and long-lasting options, are available for managing chronic obstructive pulmonary disease (COPD). A person can get a COPD inhaler through Medicare Part ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

Emond emphasized the significance of the report, highlighting that over 15 million Americans suffer from COPD. Both inhalers ...

By providing quick relief to individuals experiencing asthma symptoms at schools, stock inhalers prevent emergency room ...

Medicare usually covers the cost of inhalers for people with asthma, COPD, or certain other conditions under Part D or Medicare Advantage (Part C) plans. With Medicare coverage, you may still have ...

Compared with control patients, invited patients spent less out-of-pocket. Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for ...

There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...